{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T17:15:42Z","timestamp":1775927742821,"version":"3.50.1"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,12,21]],"date-time":"2019-12-21T00:00:00Z","timestamp":1576886400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,21]],"date-time":"2019-12-21T00:00:00Z","timestamp":1576886400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s00228-019-02785-z","type":"journal-article","created":{"date-parts":[[2019,12,21]],"date-time":"2019-12-21T18:02:46Z","timestamp":1576951366000},"page":"305-318","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Deprescribing of non-antiretroviral therapy in HIV-infected patients"],"prefix":"10.1007","volume":"76","author":[{"name":"on behalf of Gesida and SEFH","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4268-0150","authenticated-orcid":false,"given":"Jos\u00e9-Ram\u00f3n","family":"Blanco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram\u00f3n","family":"Morillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Abril","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismael","family":"Escobar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Bernal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Folguera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e1tima","family":"Bra\u00f1as","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Gimeno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olatz","family":"Ibarra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9-Antonio","family":"Iribarren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"L\u00e1zaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Mari\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda-Teresa","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esteban","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Olalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aguas","family":"Robustillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matilde","family":"Sanchez-Conde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel-Angel","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"de la Torre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Sanchez-Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montse","family":"Tuset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,21]]},"reference":[{"issue":"9903","key":"2785_CR1","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","volume":"382","author":"SG Deeks","year":"2013","unstructured":"Deeks SG, Lewin SR, Havlir DV (2013) The end of AIDS: HIV infection as a chronic disease. Lancet 382(9903):1525\u20131533. https:\/\/doi.org\/10.1016\/S0140-6736(13)61809-7","journal-title":"Lancet"},{"issue":"7","key":"2785_CR2","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S1473-3099(15)00056-0","volume":"15","author":"M Smit","year":"2015","unstructured":"Smit M, Brinkman K, Geerlings S, Smit C, Thyagarajan K, Sighem A et al (2015) Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect Dis 15(7):810\u2013818. https:\/\/doi.org\/10.1016\/S1473-3099(15)00056-0","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"2785_CR3","doi-asserted-by":"publisher","first-page":"120","DOI":"10.7399\/fh.10931","volume":"42","author":"R Morillo-Verdugo","year":"2018","unstructured":"Morillo-Verdugo R, Blanco Ramos JR, Abdel-Kader Martin L, Alvarez de Sotomayor M (2018) The challenge of aging and pharmacoterapeutic complexity in the HIV + patient. Farm Hosp 42(3):120\u2013127. https:\/\/doi.org\/10.7399\/fh.10931","journal-title":"Farm Hosp"},{"issue":"8","key":"2785_CR4","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s40266-013-0093-9","volume":"30","author":"EJ Edelman","year":"2013","unstructured":"Edelman EJ, Gordon KS, Glover J, McNicholl IR, Fiellin DA, Justice AC (2013) The next therapeutic challenge in HIV: polypharmacy. Drugs Aging 30(8):613\u2013628. https:\/\/doi.org\/10.1007\/s40266-013-0093-9","journal-title":"Drugs Aging"},{"issue":"11","key":"2785_CR5","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.2165\/11592030-000000000-00000","volume":"34","author":"AB Dequito","year":"2011","unstructured":"Dequito AB, Mol PG, van Doormaal JE, Zaal RJ, van den Bemt PM, Haaijer-Ruskamp FM et al (2011) Preventable and non-preventable adverse drug events in hospitalized patients: a prospective chart review in the Netherlands. Drug Saf 34(11):1089\u20131100. https:\/\/doi.org\/10.2165\/11592030-000000000-00000","journal-title":"Drug Saf"},{"issue":"1","key":"2785_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11096-013-9871-z","volume":"36","author":"E Reeve","year":"2014","unstructured":"Reeve E, Wiese MD (2014) Benefits of deprescribing on patients\u2019 adherence to medications. Int J Clin Pharm 36(1):26\u201329. https:\/\/doi.org\/10.1007\/s11096-013-9871-z","journal-title":"Int J Clin Pharm"},{"issue":"6","key":"2785_CR7","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/bcp.12292","volume":"77","author":"RA Payne","year":"2014","unstructured":"Payne RA, Abel GA, Avery AJ, Mercer SW, Roland MO (2014) Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care. Br J Clin Pharmacol 77(6):1073\u20131082. https:\/\/doi.org\/10.1111\/bcp.12292","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"2785_CR8","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1007\/s00520-015-2970-8","volume":"24","author":"JP Turner","year":"2016","unstructured":"Turner JP, Jamsen KM, Shakib S, Singhal N, Prowse R, Bell JS (2016) Polypharmacy cut-points in older people with cancer: how many medications are too many? Support Care Cancer 24(4):1831\u20131840. https:\/\/doi.org\/10.1007\/s00520-015-2970-8","journal-title":"Support Care Cancer"},{"issue":"12","key":"2785_CR9","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.2165\/11319530-000000000-00000","volume":"26","author":"J Jyrkka","year":"2009","unstructured":"Jyrkka J, Enlund H, Korhonen MJ, Sulkava R, Hartikainen S (2009) Polypharmacy status as an indicator of mortality in an elderly population. Drugs Aging 26(12):1039\u20131048. https:\/\/doi.org\/10.2165\/11319530-000000000-00000","journal-title":"Drugs Aging"},{"issue":"9826","key":"2785_CR10","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/S0140-6736(12)60209-8","volume":"379","author":"PM Rothwell","year":"2012","unstructured":"Rothwell PM, Wilson M, Price JF, Belch JF, Meade TW, Mehta Z (2012) Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet 379(9826):1591\u20131601. https:\/\/doi.org\/10.1016\/S0140-6736(12)60209-8","journal-title":"Lancet"},{"issue":"5","key":"2785_CR11","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/bcp.12555","volume":"79","author":"S Cullinan","year":"2015","unstructured":"Cullinan S, Fleming A, O\u2019Mahony D, Ryan C, O\u2019Sullivan D, Gallagher P, Byrne S (2015) Doctors\u2019 perspectives on the barriers to appropriate prescribing in older hospitalized patients: a qualitative study. Br J Clin Pharmacol 79(5):860\u2013869. https:\/\/doi.org\/10.1111\/bcp.12555","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"2785_CR12","doi-asserted-by":"publisher","first-page":"618","DOI":"10.7399\/fh.10778","volume":"41","author":"C Bastida","year":"2017","unstructured":"Bastida C, Grau A, Marquez M, Tuset M, De Lazzari E, Martinez E et al (2017) Polypharmacy and potential drug-drug interactions in an HIV-infected elderly population. Farm Hosp 41(5):618\u2013624. https:\/\/doi.org\/10.7399\/fh.10778","journal-title":"Farm Hosp"},{"issue":"12","key":"2785_CR13","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1002\/phar.2043","volume":"37","author":"IR McNicholl","year":"2017","unstructured":"McNicholl IR, Gandhi M, Hare CB, Greene M, Pierluissi E (2017) A pharmacist-led program to evaluate and reduce polypharmacy and potentially inappropriate prescribing in older HIV-positive patients. Pharmacotherapy 37(12):1498\u20131506. https:\/\/doi.org\/10.1002\/phar.2043","journal-title":"Pharmacotherapy"},{"key":"2785_CR14","doi-asserted-by":"publisher","first-page":"749","DOI":"10.2147\/cia.s37738","volume":"8","author":"LJ Gleason","year":"2013","unstructured":"Gleason LJ, Luque AE, Shah K (2013) Polypharmacy in the HIV-infected older adult population. Clin Interv Aging 8:749\u2013763. https:\/\/doi.org\/10.2147\/cia.s37738","journal-title":"Clin Interv Aging"},{"key":"2785_CR15","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.2147\/CIA.S108072","volume":"11","author":"M Gimeno-Gracia","year":"2016","unstructured":"Gimeno-Gracia M, Crusells-Canales MJ, Armesto-Gomez FJ, Compaired-Turlan V, Rabanaque-Hernandez MJ (2016) Polypharmacy in older adults with human immunodeficiency virus infection compared with the general population. Clin Interv Aging 11:1149\u20131157. https:\/\/doi.org\/10.2147\/CIA.S108072","journal-title":"Clin Interv Aging"},{"issue":"2","key":"2785_CR16","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/jac\/dkw437","volume":"72","author":"G Guaraldi","year":"2017","unstructured":"Guaraldi G, Menozzi M, Zona S, Calcagno A, Silva AR, Santoro A, Malagoli A, Dolci G, Mussi C, Mussini C, Cesari M, Khoo SH (2017) Impact of polypharmacy on antiretroviral prescription in people living with HIV. J Antimicrob Chemother 72(2):511\u2013514. https:\/\/doi.org\/10.1093\/jac\/dkw437","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"2785_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1089\/apc.2015.0199","volume":"30","author":"HB Krentz","year":"2016","unstructured":"Krentz HB, Gill MJ (2016) The impact of non-antiretroviral polypharmacy on the continuity of antiretroviral therapy (ART) among HIV patients. AIDS Patient Care STDs 30(1):11\u201317. https:\/\/doi.org\/10.1089\/apc.2015.0199","journal-title":"AIDS Patient Care STDs"},{"issue":"12","key":"2785_CR18","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1080\/09540121.2015.1109583","volume":"27","author":"HN Moore","year":"2015","unstructured":"Moore HN, Mao L, Oramasionwu CU (2015) Factors associated with polypharmacy and the prescription of multiple medications among persons living with HIV (PLWH) compared to non-PLWH. AIDS Care 27(12):1443\u20131448. https:\/\/doi.org\/10.1080\/09540121.2015.1109583","journal-title":"AIDS Care"},{"issue":"6","key":"2785_CR19","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1097\/qad.0000000000001756","volume":"32","author":"AC Justice","year":"2018","unstructured":"Justice AC, Gordon KS, Skanderson M, Edelman EJ, Akgun KM, Gibert CL et al (2018) Nonantiretroviral polypharmacy and adverse health outcomes among HIV-infected and uninfected individuals. AIDS 32(6):739\u2013749. https:\/\/doi.org\/10.1097\/qad.0000000000001756","journal-title":"AIDS"},{"issue":"9","key":"2785_CR20","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1345\/aph.1D479","volume":"38","author":"J George","year":"2004","unstructured":"George J, Phun YT, Bailey MJ, Kong DC, Stewart K (2004) Development and validation of the medication regimen complexity index. Ann Pharmacother 38(9):1369\u20131376. https:\/\/doi.org\/10.1345\/aph.1D479","journal-title":"Ann Pharmacother"},{"issue":"1","key":"2785_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12877-017-0558-5","volume":"17","author":"M Bazargan","year":"2017","unstructured":"Bazargan M, Smith J, Yazdanshenas H, Movassaghi M, Martins D, Orum G (2017) Non-adherence to medication regimens among older African-American adults. BMC Geriatr 17(1):163. https:\/\/doi.org\/10.1186\/s12877-017-0558-5","journal-title":"BMC Geriatr"},{"issue":"4","key":"2785_CR22","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1086\/596482","volume":"48","author":"JJ Parienti","year":"2009","unstructured":"Parienti JJ, Bangsberg DR, Verdon R, Gardner EM (2009) Better adherence with once-daily antiretroviral regimens: a meta-analysis. Clin Infect Dis 48(4):484\u2013488. https:\/\/doi.org\/10.1086\/596482","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2785_CR23","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1258\/ijsa.2011.011292","volume":"23","author":"A Buscher","year":"2012","unstructured":"Buscher A, Hartman C, Kallen MA, Giordano TP (2012) Impact of antiretroviral dosing frequency and pill burden on adherence among newly diagnosed, antiretroviral-naive HIV patients. Int J STD AIDS 23(5):351\u2013355. https:\/\/doi.org\/10.1258\/ijsa.2011.011292","journal-title":"Int J STD AIDS"},{"issue":"4","key":"2785_CR24","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/jgs.14682","volume":"65","author":"BC Wimmer","year":"2017","unstructured":"Wimmer BC, Cross AJ, Jokanovic N, Wiese MD, George J, Johnell K et al (2017) Clinical outcomes associated with medication regimen complexity in older people: a systematic review. J Am Geriatr Soc 65(4):747\u2013753. https:\/\/doi.org\/10.1111\/jgs.14682","journal-title":"J Am Geriatr Soc"},{"issue":"10","key":"2785_CR25","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1007\/s11606-013-2449-6","volume":"28","author":"C Holtzman","year":"2013","unstructured":"Holtzman C, Armon C, Tedaldi E, Chmiel JS, Buchacz K, Wood K, Brooks JT, and the HOPS Investigators (2013) Polypharmacy and risk of antiretroviral drug interactions among the aging HIV-infected population. J Gen Intern Med 28(10):1302\u20131310. https:\/\/doi.org\/10.1007\/s11606-013-2449-6","journal-title":"J Gen Intern Med"},{"issue":"11","key":"2785_CR26","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1177\/1060028013504075","volume":"47","author":"A Tseng","year":"2013","unstructured":"Tseng A, Szadkowski L, Walmsley S, Salit I, Raboud J (2013) Association of age with polypharmacy and risk of drug interactions with antiretroviral medications in HIV-positive patients. Ann Pharmacother 47(11):1429\u20131439. https:\/\/doi.org\/10.1177\/1060028013504075","journal-title":"Ann Pharmacother"},{"key":"2785_CR27","unstructured":"Documento de consenso sobre edad avanzada e infecci\u00f3n por el virus de la inmunodeficiencia humana. Grupo de expertos de la Secretar\u00eda del Plan Nacional sobre el sida (SPNS), Sociedad Espa\u00f1ola de Geriatr\u00eda y Gerontolog\u00eda (SEGG). 2015. Available at: https:\/\/www.msssi.gob.es\/ciudadanos\/enfLesiones\/enfTransmisibles\/sida\/publicaciones\/profSanitarios\/docEdadAvanzadaVIH.pdf"},{"issue":"1","key":"2785_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/17512433.2017.1246180","volume":"10","author":"KM Brooks","year":"2017","unstructured":"Brooks KM, George JM, Kumar P (2017) Drug interactions in HIV treatment: complementary & alternative medicines and over-the-counter products. Expert Rev Clin Pharmacol 10(1):59\u201379. https:\/\/doi.org\/10.1080\/17512433.2017.1246180","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"12","key":"2785_CR29","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1111\/jgs.13153","volume":"62","author":"TR Fried","year":"2014","unstructured":"Fried TR, O\u2019Leary J, Towle V, Goldstein MK, Trentalange M, Martin DK (2014) Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc 62(12):2261\u20132272. https:\/\/doi.org\/10.1111\/jgs.13153","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"2785_CR30","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1159\/000365328","volume":"61","author":"C Gomez","year":"2015","unstructured":"Gomez C, Vega-Quiroga S, Bermejo-Pareja F, Medrano MJ, Louis ED, Benito-Leon J (2015) Polypharmacy in the elderly: a marker of increased risk of mortality in a population-based prospective study (NEDICES). Gerontology 61(4):301\u2013309. https:\/\/doi.org\/10.1159\/000365328","journal-title":"Gerontology"},{"issue":"9","key":"2785_CR31","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jclinepi.2012.02.018","volume":"65","author":"D Gnjidic","year":"2012","unstructured":"Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, Waite L, Seibel MJ et al (2012) Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol 65(9):989\u2013995. https:\/\/doi.org\/10.1016\/j.jclinepi.2012.02.018","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"2785_CR32","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/jgs.12695","volume":"62","author":"M Greene","year":"2014","unstructured":"Greene M, Steinman MA, McNicholl IR, Valcour V (2014) Polypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults with human immunodeficiency virus infection. J Am Geriatr Soc 62(3):447\u2013453. https:\/\/doi.org\/10.1111\/jgs.12695","journal-title":"J Am Geriatr Soc"},{"issue":"9","key":"2785_CR33","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/hiv.12296","volume":"16","author":"R Acquah","year":"2015","unstructured":"Acquah R, Graham H, Winter A (2015) Quantifying polypharmacy in a large HIV-infected cohort. HIV Med 16(9):583\u2013584. https:\/\/doi.org\/10.1111\/hiv.12296","journal-title":"HIV Med"},{"issue":"3","key":"2785_CR34","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3851\/imp1540","volume":"15","author":"C Marzolini","year":"2010","unstructured":"Marzolini C, Elzi L, Gibbons S, Weber R, Fux C, Furrer H et al (2010) Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV cohort study. Antivir Ther 15(3):413\u2013423. https:\/\/doi.org\/10.3851\/imp1540","journal-title":"Antivir Ther"},{"issue":"1","key":"2785_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/qad.0000000000001685","volume":"32","author":"KJ Siefried","year":"2018","unstructured":"Siefried KJ, Mao L, Cysique LA, Rule J, Giles ML, Smith DE et al (2018) Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy. AIDS 32(1):35\u201348. https:\/\/doi.org\/10.1097\/qad.0000000000001685","journal-title":"AIDS"},{"issue":"5","key":"2785_CR36","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/QAI.0b013e31811ed1f1","volume":"45","author":"S Martin","year":"2007","unstructured":"Martin S, Wolters PL, Calabrese SK, Toledo-Tamula MA, Wood LV, Roby G et al (2007) The antiretroviral regimen complexity index. A novel method of quantifying regimen complexity. J Acquir Immune Defic Syndr 45(5):535\u2013544. https:\/\/doi.org\/10.1097\/QAI.0b013e31811ed1f1","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"2785_CR37","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.clinthera.2013.02.019","volume":"35","author":"AM Libby","year":"2013","unstructured":"Libby AM, Fish DN, Hosokawa PW, Linnebur SA, Metz KR, Nair KV, Saseen JJ, Vande Griend JP, Vu SP, Hirsch JD (2013) Patient-level medication regimen complexity across populations with chronic disease. Clin Ther 35(4):385\u2013398 e381. https:\/\/doi.org\/10.1016\/j.clinthera.2013.02.019","journal-title":"Clin Ther"},{"issue":"9","key":"2785_CR38","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1177\/1060028014539642","volume":"48","author":"KR Metz","year":"2014","unstructured":"Metz KR, Fish DN, Hosokawa PW, Hirsch JD, Libby AM (2014) Patient-level medication regimen complexity in patients with HIV. Ann Pharmacother 48(9):1129\u20131137. https:\/\/doi.org\/10.1177\/1060028014539642","journal-title":"Ann Pharmacother"},{"issue":"14","key":"2785_CR39","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/archinternmed.2009.229","volume":"169","author":"I Carriere","year":"2009","unstructured":"Carriere I, Fourrier-Reglat A, Dartigues JF, Rouaud O, Pasquier F, Ritchie K et al (2009) Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch Intern Med 169(14):1317\u20131324. https:\/\/doi.org\/10.1001\/archinternmed.2009.229","journal-title":"Arch Intern Med"},{"issue":"8","key":"2785_CR40","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1111\/j.1532-5415.2011.03491.x","volume":"59","author":"C Fox","year":"2011","unstructured":"Fox C, Richardson K, Maidment ID, Savva GM, Matthews FE, Smithard D, Coulton S, Katona C, Boustani MA, Brayne C (2011) Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. J Am Geriatr Soc 59(8):1477\u20131483. https:\/\/doi.org\/10.1111\/j.1532-5415.2011.03491.x","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"2785_CR41","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/j.1532-5415.2011.03386.x","volume":"59","author":"NM Wilson","year":"2011","unstructured":"Wilson NM, Hilmer SN, March LM, Cameron ID, Lord SR, Seibel MJ, Mason RS, Chen JS, Cumming RG, Sambrook PN (2011) Associations between drug burden index and falls in older people in residential aged care. J Am Geriatr Soc 59(5):875\u2013880. https:\/\/doi.org\/10.1111\/j.1532-5415.2011.03386.x","journal-title":"J Am Geriatr Soc"},{"key":"2785_CR42","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2318-15-2","volume":"15","author":"CA Alvarez","year":"2015","unstructured":"Alvarez CA, Mortensen EM, Makris UE, Berlowitz DR, Copeland LA, Good CB, Amuan ME, Pugh MJ (2015) Association of skeletal muscle relaxers and antihistamines on mortality, hospitalizations, and emergency department visits in elderly patients: a nationwide retrospective cohort study. BMC Geriatr 15:2. https:\/\/doi.org\/10.1186\/1471-2318-15-2","journal-title":"BMC Geriatr"},{"issue":"1","key":"2785_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7399\/fh.10842","volume":"42","author":"A Casajus-Navasal","year":"2018","unstructured":"Casajus-Navasal A, Marin-Gorricho R, Gallardo-Anciano J, Nebot-Villacampa MJ, Zafra-Morales R, Gonzalez-Perez Y (2018) Prevalence of the consumption of anticholinergic drugs in HIV patients. Farm Hosp 42(1):1\u20134. https:\/\/doi.org\/10.7399\/fh.10842","journal-title":"Farm Hosp"},{"key":"2785_CR44","unstructured":"Anti-Cholinergic Burden (ACB) Scale. Available at: http:\/\/www.miltonkeynesccg.nhs.uk\/resources\/uploads\/ACB_scale_-_legal_size.pdf"},{"issue":"5","key":"2785_CR45","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1001\/archinternmed.2007.106","volume":"168","author":"JL Rudolph","year":"2008","unstructured":"Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE (2008) The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Inter Med 168(5):508\u2013513. https:\/\/doi.org\/10.1001\/archinternmed.2007.106","journal-title":"Arch Inter Med"},{"issue":"8","key":"2785_CR46","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1001\/archinte.167.8.781","volume":"167","author":"SN Hilmer","year":"2007","unstructured":"Hilmer SN, Mager DE, Simonsick EM, Cao Y, Ling SM, Windham BG et al (2007) A drug burden index to define the functional burden of medications in older people. Arch Intern Med 167(8):781\u2013787. https:\/\/doi.org\/10.1001\/archinte.167.8.781","journal-title":"Arch Intern Med"},{"issue":"1","key":"2785_CR47","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-018880","volume":"8","author":"MA Mohammed","year":"2018","unstructured":"Mohammed MA, Moles RJ, Hilmer SN, Kouladjian O\u2019Donnel L, Chen TF (2018) Development and validation of an instrument for measuring the burden of medicine on functioning and well-being: the Medication-Related Burden Quality of Life (MRB-QoL) tool. BMJ Open 8(1):e018880. https:\/\/doi.org\/10.1136\/bmjopen-2017-018880","journal-title":"BMJ Open"},{"issue":"11","key":"2785_CR48","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1111\/jgs.13702","volume":"63","author":"By the American Geriatrics Society Beers Criteria Update Expert P","year":"2015","unstructured":"By the American Geriatrics Society Beers Criteria Update Expert P (2015) American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 63(11):2227\u20132246. https:\/\/doi.org\/10.1111\/jgs.13702","journal-title":"J Am Geriatr Soc"},{"issue":"31\u201332","key":"2785_CR49","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3238\/arztebl.2010.0543","volume":"107","author":"S Holt","year":"2010","unstructured":"Holt S, Schmiedl S, Thurmann PA (2010) Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int 107(31\u201332):543\u2013551. https:\/\/doi.org\/10.3238\/arztebl.2010.0543","journal-title":"Dtsch Arztebl Int"},{"issue":"9","key":"2785_CR50","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.jamda.2013.07.004","volume":"14","author":"J Vance","year":"2013","unstructured":"Vance J (2013) AMDA-choosing wisely. J Am Med Dir Assoc 14(9):639\u2013641. https:\/\/doi.org\/10.1016\/j.jamda.2013.07.004","journal-title":"J Am Med Dir Assoc"},{"issue":"2","key":"2785_CR51","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/jcpt.12372","volume":"41","author":"B Hill-Taylor","year":"2016","unstructured":"Hill-Taylor B, Walsh KA, Stewart S, Hayden J, Byrne S, Sketris IS (2016) Effectiveness of the STOPP\/START (Screening Tool of Older Persons\u2019 potentially inappropriate Prescriptions\/Screening Tool to Alert doctors to the Right Treatment) criteria: systematic review and meta-analysis of randomized controlled studies. J Clin Pharm Ther 41(2):158\u2013169. https:\/\/doi.org\/10.1111\/jcpt.12372","journal-title":"J Clin Pharm Ther"},{"issue":"4","key":"2785_CR52","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1093\/ageing\/afx005","volume":"46","author":"AH Lavan","year":"2017","unstructured":"Lavan AH, Gallagher P, Parsons C, O\u2019Mahony D (2017) STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy): consensus validation. Age Ageing 46(4):600\u2013607. https:\/\/doi.org\/10.1093\/ageing\/afx005","journal-title":"Age Ageing"},{"issue":"10081","key":"2785_CR53","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/S0140-6736(17)31188-1","volume":"389","author":"PA Rochon","year":"2017","unstructured":"Rochon PA, Gurwitz JH (2017) The prescribing cascade revisited. Lancet 389(10081):1778\u20131780. https:\/\/doi.org\/10.1016\/S0140-6736(17)31188-1","journal-title":"Lancet"},{"issue":"8966","key":"2785_CR54","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0140-6736(95)92656-9","volume":"346","author":"PA Rochon","year":"1995","unstructured":"Rochon PA, Gurwitz JH (1995) Drug therapy. Lancet 346(8966):32\u201336","journal-title":"Lancet"},{"issue":"7115","key":"2785_CR55","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1136\/bmj.315.7115.1096","volume":"315","author":"PA Rochon","year":"1997","unstructured":"Rochon PA, Gurwitz JH (1997) Optimising drug treatment for elderly people: the prescribing cascade. BMJ 315(7115):1096\u20131099","journal-title":"BMJ"},{"key":"2785_CR56","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/jppr2003334323","volume":"33","author":"M Woodward","year":"2003","unstructured":"Woodward M (2003) Deprescribing: achieving better health outcomes for older people through reducing medications. J Pharm Pract Res 33:323\u2013328","journal-title":"J Pharm Pract Res"},{"issue":"8","key":"2785_CR57","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s00228-017-2257-8","volume":"73","author":"E Reeve","year":"2017","unstructured":"Reeve E, Ong M, Wu A, Jansen J, Petrovic M, Gnjidic D (2017) A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people. Eur J Clin Pharmacol 73(8):927\u2013935. https:\/\/doi.org\/10.1007\/s00228-017-2257-8","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"2785_CR58","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","volume":"175","author":"IA Scott","year":"2015","unstructured":"Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D et al (2015) Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med 175(5):827\u2013834. https:\/\/doi.org\/10.1001\/jamainternmed.2015.0324","journal-title":"JAMA Intern Med"},{"issue":"2","key":"2785_CR59","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/14740338.2017.1273347","volume":"16","author":"JE Machado-Alba","year":"2017","unstructured":"Machado-Alba JE, Gaviria-Mendoza A, Machado-Duque ME, Chica L (2017) Deprescribing: a new goal focused on the patient. Expert Opin Drug Saf 16(2):111\u2013112. https:\/\/doi.org\/10.1080\/14740338.2017.1273347","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"2785_CR60","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/bcp.12975","volume":"82","author":"AT Page","year":"2016","unstructured":"Page AT, Clifford RM, Potter K, Schwartz D, Etherton-Beer CD (2016) The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis. Br J Clin Pharmacol 82(3):583\u2013623. https:\/\/doi.org\/10.1111\/bcp.12975","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"2785_CR61","doi-asserted-by":"publisher","first-page":"390","DOI":"10.5694\/mja14.00146","volume":"201","author":"IA Scott","year":"2014","unstructured":"Scott IA, Anderson K, Freeman CR, Stowasser DA (2014) First do no harm: a real need to deprescribe in older patients. Med J Aust 201(7):390\u2013392","journal-title":"Med J Aust"},{"key":"2785_CR62","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2016.12.021","volume":"38","author":"E Reeve","year":"2017","unstructured":"Reeve E, Thompson W, Farrell B (2017) Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action. European J Int Med 38:3\u201311. https:\/\/doi.org\/10.1016\/j.ejim.2016.12.021","journal-title":"European J Int Med"},{"issue":"3","key":"2785_CR63","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/imj.12693","volume":"45","author":"IA Scott","year":"2015","unstructured":"Scott IA, Le Couteur DG (2015) Physicians need to take the lead in deprescribing. Intern Med J 45(3):352\u2013356. https:\/\/doi.org\/10.1111\/imj.12693","journal-title":"Intern Med J"},{"issue":"8","key":"2785_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161248","volume":"11","author":"B Farrell","year":"2016","unstructured":"Farrell B, Pottie K, Rojas-Fernandez CH, Bjerre LM, Thompson W, Welch V (2016) Methodology for developing deprescribing guidelines: using evidence and GRADE to guide recommendations for deprescribing. PLoS One 11(8):e0161248. https:\/\/doi.org\/10.1371\/journal.pone.0161248","journal-title":"PLoS One"},{"issue":"2","key":"2785_CR65","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1089\/jpm.2017.0688","volume":"21","author":"E Phung","year":"2018","unstructured":"Phung E, Triantafylidis L, Zhang HM, Yeh IM (2018) New media, part 5: online deprescribing tools. J Palliat Med 21(2):269\u2013270. https:\/\/doi.org\/10.1089\/jpm.2017.0688","journal-title":"J Palliat Med"},{"issue":"10","key":"2785_CR66","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s40266-013-0106-8","volume":"30","author":"E Reeve","year":"2013","unstructured":"Reeve E, To J, Hendrix I, Shakib S, Roberts MS, Wiese MD (2013) Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging 30(10):793\u2013807. https:\/\/doi.org\/10.1007\/s40266-013-0106-8","journal-title":"Drugs Aging"},{"key":"2785_CR67","unstructured":"Deprescribing tools. Available at: http:\/\/www.nswtag.org.au\/deprescribing-tools\/"},{"issue":"11","key":"2785_CR68","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s40266-013-0118-4","volume":"30","author":"JT Hanlon","year":"2013","unstructured":"Hanlon JT, Schmader KE (2013) The medication appropriateness index at 20: where it started, where it has been, and where it may be going. Drugs Aging 30(11):893\u2013900. https:\/\/doi.org\/10.1007\/s40266-013-0118-4","journal-title":"Drugs Aging"},{"issue":"4","key":"2785_CR69","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/intqhc\/12.4.281","volume":"12","author":"RH Brook","year":"2000","unstructured":"Brook RH, McGlynn EA, Shekelle PG (2000) Defining and measuring quality of care: a perspective from US researchers. Int J Qual Health Care 12(4):281\u2013295","journal-title":"Int J Qual Health Care"},{"key":"2785_CR70","unstructured":"Stockl KM, Le L, Zhang S, Harada AS (2010) Clinical and economic outcomes associated with potentially inappropriate prescribing in the elderly. Am J Manag Care 16 (1): e1\u201310"},{"issue":"4","key":"2785_CR71","first-page":"265","volume":"69","author":"G Brown","year":"2016","unstructured":"Brown G (2016) Protecting our elderly patients from adverse drug reactions. Can J Hosp Pharm 69(4):265\u2013266","journal-title":"Can J Hosp Pharm"},{"issue":"8","key":"2785_CR72","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1111\/jgs.14312","volume":"64","author":"MN O\u2019Connor","year":"2016","unstructured":"O\u2019Connor MN, O\u2019Sullivan D, Gallagher PF, Eustace J, Byrne S, O\u2019Mahony D (2016) Prevention of hospital-acquired adverse drug reactions in older people using screening tool of older persons\u2019 prescriptions and screening tool to alert to right treatment criteria: a cluster randomized controlled trial. J Am Geriatr Soc 64(8):1558\u20131566. https:\/\/doi.org\/10.1111\/jgs.14312","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"2785_CR73","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s40266-016-0371-4","volume":"33","author":"Farhad Pazan","year":"2016","unstructured":"Pazan F, Weiss C, Wehling M, Forta (2016) The FORTA (fit fOR the aged) list 2015: update of a validated clinical tool for improved pharmacotherapy in the elderly. Drugs Aging 33 (6): 447\u2013449 DOI https:\/\/doi.org\/10.1007\/s40266-016-0371-4","journal-title":"Drugs & Aging"},{"key":"2785_CR74","unstructured":"Morillo Verdugo R, Robustillo Cort\u00e9s M, Gimeno Gracia M, S\u00e1nchez-Rubio Ferr\u00e1ndez J, Guzm\u00e1n Ramos M. Prevalencia, factores asociados y complejidad farmacoterap\u00e9utica de la polifarmacia en pacientes VIH+ en Espa\u00f1a. Estudio POINT. En: 62 Congreso SEFH. Madrid, 2017."},{"issue":"5","key":"2785_CR75","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/hiv.12205","volume":"16","author":"C Iniesta-Navalon","year":"2015","unstructured":"Iniesta-Navalon C, Franco-Miguel JJ, Gascon-Canovas JJ, Rentero-Redondo L (2015) Identification of potential clinically significant drug interactions in HIV-infected patients: a comprehensive therapeutic approach. HIV Med 16(5):273\u2013279. https:\/\/doi.org\/10.1111\/hiv.12205","journal-title":"HIV Med"},{"issue":"2","key":"2785_CR76","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s11096-016-0279-4","volume":"38","author":"A Galazzi","year":"2016","unstructured":"Galazzi A, Lusignani M, Chiarelli MT, Mannucci PM, Franchi C, Tettamanti M, Reeve E, Nobili A (2016) Attitudes towards polypharmacy and medication withdrawal among older inpatients in Italy. Int J Clin Pharm 38(2):454\u2013461. https:\/\/doi.org\/10.1007\/s11096-016-0279-4","journal-title":"Int J Clin Pharm"},{"issue":"9","key":"2785_CR77","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1111\/jgs.12418","volume":"61","author":"E Reeve","year":"2013","unstructured":"Reeve E, Wiese MD, Hendrix I, Roberts MS, Shakib S (2013) People\u2019s attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe. J Am Geriatr Soc 61(9):1508\u20131514. https:\/\/doi.org\/10.1111\/jgs.12418","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"2785_CR78","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1136\/ejhpharm-2016-000989","volume":"24","author":"S Barnett-Cormack","year":"2017","unstructured":"Barnett-Cormack S (2017) Managing medicines in multimorbidity: a patient perspective. Eur J Hosp Pharm 24(1):34\u201336","journal-title":"Eur J Hosp Pharm"},{"issue":"6","key":"2785_CR79","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s40266-018-0544-4","volume":"35","author":"BJ Ng","year":"2018","unstructured":"Ng BJ, Le Couteur DG, Hilmer SN (2018) Deprescribing benzodiazepines in older patients: impact of interventions targeting physicians, pharmacists, and patients. Drugs Aging 35(6):493\u2013521. https:\/\/doi.org\/10.1007\/s40266-018-0544-4","journal-title":"Drugs Aging"},{"issue":"2","key":"2785_CR80","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/QAI.0000000000000591","volume":"69","author":"DF Weisberg","year":"2015","unstructured":"Weisberg DF, Gordon KS, Barry DT, Becker WC, Crystal S, Edelman EJ et al (2015) Long-term prescription of opioids and\/or benzodiazepines and mortality among HIV-infected and uninfected patients. J Acquir Immune Def Syndr 69(2):223\u2013233. https:\/\/doi.org\/10.1097\/QAI.0000000000000591","journal-title":"J Acquir Immune Def Syndr"},{"issue":"6","key":"2785_CR81","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","volume":"174","author":"C Tannenbaum","year":"2014","unstructured":"Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S (2014) Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med 174(6):890\u2013898. https:\/\/doi.org\/10.1001\/jamainternmed.2014.949","journal-title":"JAMA Intern Med"},{"key":"2785_CR82","unstructured":"G\u00f3mez EM, N\u00fa\u00f1ez MP, L\u00f3pez AT, Guerra ME, Castellano JL, Mart\u00edn A, et al. Bolet\u00edn Canario del uso racional del medicamento del SCS. Desprescripci\u00f3n de benzodiacepinas e hipn\u00f3ticos Z. Available at: https:\/\/www3.gobiernodecanarias.org\/sanidad\/scs\/\/content\/cbb1e679-c080-11e7-b97c-85a2cbf90b08\/Vol9_n2BOLCAN_DesprescripBZD_SEP 2017.pdf"},{"issue":"1","key":"2785_CR83","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1136\/ejhpharm-2016-001044","volume":"24","author":"A Mair","year":"2017","unstructured":"Mair A, Fernandez-Llimos F, Consortium S (2017) Polypharmacy management programmes: the SIMPATHY Project. Eur J Hosp Pharm 24(1):5\u20136","journal-title":"Eur J Hosp Pharm"},{"issue":"4","key":"2785_CR84","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.regg.2012.01.003","volume":"47","author":"E Gavilan-Moral","year":"2012","unstructured":"Gavilan-Moral E, Villafaina-Barroso A, Jimenez-de Gracia L, Gomez Santana Mdel C (2012) Polypharmacy in frail elderly patients: is deprescribing the answer? Rev Esp Geriatr Gerontol 47(4):162\u2013167. https:\/\/doi.org\/10.1016\/j.regg.2012.01.003","journal-title":"Rev Esp Geriatr Gerontol"},{"issue":"12","key":"2785_CR85","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.2165\/0002512-200825120-00004","volume":"25","author":"S Iyer","year":"2008","unstructured":"Iyer S, Naganathan V, McLachlan AJ, Le Couteur DG (2008) Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Aging 25(12):1021\u20131031. https:\/\/doi.org\/10.2165\/0002512-200825120-00004","journal-title":"Drugs Aging"},{"issue":"18","key":"2785_CR86","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1001\/archinternmed.2010.355","volume":"170","author":"D Garfinkel","year":"2010","unstructured":"Garfinkel D, Mangin D (2010) Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med 170(18):1648\u20131654. https:\/\/doi.org\/10.1001\/archinternmed.2010.355","journal-title":"Arch Intern Med"},{"key":"2785_CR87","unstructured":"Gavil\u00e1n E, Villafaina A, Ar\u00e1nguez A, S\u00e1nchez G, Suliman S, Jim\u00e9nez L. \u00cdndice de adecuaci\u00f3n de los medicamentos: versi\u00f3n espa\u00f1ola modificada y gu\u00eda del usuario. Laboratorio de Pr\u00e1cticas Innovadoras en Polimedicaci\u00f3n y Salud; 2012."},{"issue":"Suppl 1","key":"2785_CR88","doi-asserted-by":"publisher","first-page":"A103.2-A104","DOI":"10.1136\/ejhpharm-2013-000436.254","volume":"21","author":"A Rodr\u00edguez-Perez","year":"2014","unstructured":"Rodr\u00edguez-Perez A, Gonz\u00e1lez-Bueno J, Alfaro-Lara E, Toscano-Guzm\u00e1n M, Sierra-Torres M, Villalba-Moreno A. DI-083 Deprescribing strategies in elderly patients or patients with several chronic conditions. Eur J Hosp Pharm Sci Pract 2014; 21(Suppl1):A103-A104.","journal-title":"European Journal of Hospital Pharmacy"},{"issue":"4","key":"2785_CR89","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122246","volume":"10","author":"B Farrell","year":"2015","unstructured":"Farrell B, Tsang C, Raman-Wilms L, Irving H, Conklin J, Pottie K (2015) What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process. PLoS One 10(4):e0122246. https:\/\/doi.org\/10.1371\/journal.pone.0122246","journal-title":"PLoS One"},{"key":"2785_CR90","unstructured":"Renom-Guiteras A. El proceso de deprescribir en el anciano. Rev Multidiscipl Gerontol 2017. Available at: http:\/\/scgig.cat\/wp-content\/uploads\/2017\/10\/REVISTA_SCGIG_02_EDITORIAL_CAST_ok.pdf"},{"issue":"6","key":"2785_CR91","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/ageing\/afl075","volume":"35","author":"AG Zermansky","year":"2006","unstructured":"Zermansky AG, Alldred DP, Petty DR, Raynor DK, Freemantle N, Eastaugh J et al (2006) Clinical medication review by a pharmacist of elderly people living in care homes--randomised controlled trial. Age Ageing 35(6):586\u2013591. https:\/\/doi.org\/10.1093\/ageing\/afl075","journal-title":"Age Ageing"},{"key":"2785_CR92","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13012-015-0268-3","volume":"10","author":"C Richter","year":"2015","unstructured":"Richter C, Berg A, Fleischer S, Kopke S, Balzer K, Fick EM et al (2015) Effect of person-centred care on antipsychotic drug use in nursing homes (EPCentCare): study protocol for a cluster-randomised controlled trial. Implement Sci 10:82\u201310. https:\/\/doi.org\/10.1186\/s13012-015-0268-3","journal-title":"Implement Sci"},{"key":"2785_CR93","unstructured":"Deprescribing guidelines and algorithms. Available at: https:\/\/deprescribing.org\/resources\/deprescribing-guidelines-algorithms\/"},{"issue":"1","key":"2785_CR94","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1017\/s0714980816000702","volume":"36","author":"C Tannenbaum","year":"2017","unstructured":"Tannenbaum C, Farrell B, Shaw J, Morgan S, Trimble J, Currie J et al (2017) An ecological approach to reducing potentially inappropriate medication use: Canadian Deprescribing network. Can J Aging 36(1):97\u2013107. https:\/\/doi.org\/10.1017\/s0714980816000702","journal-title":"Can J Aging"},{"key":"2785_CR95","doi-asserted-by":"publisher","first-page":"i2893","DOI":"10.1136\/bmj.i2893","volume":"353","author":"J Jansen","year":"2016","unstructured":"Jansen J, Naganathan V, Carter SM, McLachlan AJ, Nickel B, Irwig L, Bonner C, Doust J, Colvin J, Heaney A, Turner R, McCaffery K (2016) Too much medicine in older people? Deprescribing through shared decision making. BMJ 353:i2893. https:\/\/doi.org\/10.1136\/bmj.i2893","journal-title":"BMJ"},{"key":"2785_CR96","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/j.2055-2335.2011.tb00684.x","volume":"41","author":"JE Hardy","year":"2011","unstructured":"Hardy JE, Hilmer SN (2011) Deprescribing in the last year of life. J Pharm Practice Res 41:146\u2013151","journal-title":"J Pharm Practice Res"},{"issue":"8","key":"2785_CR97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043617","volume":"7","author":"D Opondo","year":"2012","unstructured":"Opondo D, Eslami S, Visscher S, de Rooij SE, Verheij R, Korevaar JC et al (2012) Inappropriateness of medication prescriptions to elderly patients in the primary care setting: a systematic review. PLoS One 7(8):e43617. https:\/\/doi.org\/10.1371\/journal.pone.0043617","journal-title":"PLoS One"},{"key":"2785_CR98","unstructured":"Am I taking too many medications?. Available at: https:\/\/www.deprescribingnetwork.ca\/too-many-medications\/"},{"issue":"1","key":"2785_CR99","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1742-6405-10-29","volume":"10","author":"DC Hsu","year":"2013","unstructured":"Hsu DC, Sereti I, Ananworanich J (2013) Serious non-AIDS events: immunopathogenesis and interventional strategies. AIDS Res Ther 10(1):29\u201315. https:\/\/doi.org\/10.1186\/1742-6405-10-29","journal-title":"AIDS Res Ther"},{"issue":"1","key":"2785_CR100","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s11904-018-0372-5","volume":"15","author":"SM Fukui","year":"2018","unstructured":"Fukui SM, Piggott DA, Erlandson KM (2018) Inflammation strikes again: frailty and HIV. Curr HIV\/AIDS Rep 15(1):20\u201329. https:\/\/doi.org\/10.1007\/s11904-018-0372-5","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"9","key":"2785_CR101","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1089\/AID.2011.0377","volume":"28","author":"JR Blanco","year":"2012","unstructured":"Blanco JR, Jarrin I, Vallejo M, Berenguer J, Solera C, Rubio R et al (2012) Definition of advanced age in HIV infection: looking for an age cut-off. AIDS Res Hum Retrovir 28(9):1000\u20131006. https:\/\/doi.org\/10.1089\/AID.2011.0377","journal-title":"AIDS Res Hum Retrovir"},{"key":"2785_CR102","unstructured":"What is deprescribing?. Available at: https:\/\/www.deprescribingnetwork.ca\/deprescribing\/"},{"issue":"7526","key":"2785_CR103","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1136\/bmj.38623.768588.47","volume":"331","author":"J Glass","year":"2005","unstructured":"Glass J, Lanctot KL, Herrmann N, Sproule BA, Busto UE (2005) Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 331(7526):1169. https:\/\/doi.org\/10.1136\/bmj.38623.768588.47","journal-title":"BMJ"},{"issue":"5","key":"2785_CR104","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1097\/00007611-199505000-00005","volume":"88","author":"RC Hamdy","year":"1995","unstructured":"Hamdy RC, Moore SW, Whalen K, Donnelly JP, Compton R, Testerman F, Haulsee P, Hughes J (1995) Reducing polypharmacy in extended care. South Med J 88(5):534\u2013538","journal-title":"South Med J"},{"issue":"3","key":"2785_CR105","first-page":"385","volume":"156","author":"PJ McLeod","year":"1997","unstructured":"McLeod PJ, Huang AR, Tamblyn RM, Gayton DC (1997) Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 156(3):385\u2013391","journal-title":"CMAJ"},{"issue":"11","key":"2785_CR106","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1111\/ggi.13062","volume":"17","author":"A Rodriguez-Perez","year":"2017","unstructured":"Rodriguez-Perez A, Alfaro-Lara ER, Albinana-Perez S, Nieto-Martin MD, Diez-Manglano J, Perez-Guerrero C et al (2017) Novel tool for deprescribing in chronic patients with multimorbidity: list of evidence-based deprescribing for chronic patients criteria. Geriatr Gerontol Int 17(11):2200\u20132207. https:\/\/doi.org\/10.1111\/ggi.13062","journal-title":"Geriatr Gerontol Int"},{"issue":"9","key":"2785_CR107","doi-asserted-by":"publisher","first-page":"714","DOI":"10.7326\/0003-4819-140-9-200405040-00011","volume":"140","author":"T Higashi","year":"2004","unstructured":"Higashi T, Shekelle PG, Solomon DH, Knight EL, Roth C, Chang JT et al (2004) The quality of pharmacologic care for vulnerable older patients. Ann Intern Med 140(9):714\u2013720","journal-title":"Ann Intern Med"},{"issue":"9","key":"2785_CR108","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2165\/00002512-200724090-00003","volume":"24","author":"PA De Smet","year":"2007","unstructured":"De Smet PA, Denneboom W, Kramers C, Grol R (2007) A composite screening tool for medication reviews of outpatients: general issues with specific examples. Drugs Aging 24(9):733\u2013760","journal-title":"Drugs Aging"},{"issue":"5","key":"2785_CR109","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1177\/106002809703100503","volume":"31","author":"LS Fitzgerald","year":"1997","unstructured":"Fitzgerald LS, Hanlon JT, Shelton PS, Landsman PB, Schmader KE, Pulliam CC, Williams ME (1997) Reliability of a modified medication appropriateness index in ambulatory older persons. Ann Pharmacother 31(5):543\u2013548. https:\/\/doi.org\/10.1177\/106002809703100503","journal-title":"Ann Pharmacother"},{"key":"2785_CR110","unstructured":"S\u00e1nchez JL, Gonz\u00e1lez MT, Mu\u00f1oz MI, Lara S, Garc\u00eda EM. Deprescripci\u00f3n en el paciente polimedicado. Bolet\u00edn Farmacoterap\u00e9utico de Castilla-La Mancha 2015. Available at: http:\/\/sescam.castillalamancha.es\/sites\/sescam.castillalamancha.es\/files\/documentos\/farmacia\/boletin_3_2015.pdf."},{"issue":"3","key":"2785_CR111","doi-asserted-by":"publisher","first-page":"346","DOI":"10.7399\/fh.2017.41.3.10655","volume":"41","author":"R Morillo-Verdugo","year":"2017","unstructured":"Morillo-Verdugo R, Martinez-Sesmero JM, Lazaro-Lopez A, Sanchez-Rubio J, Navarro-Aznarez H, De Miguel-Cascon M (2017) Development of a risk stratification model for pharmaceutical care in HIV patients. Farm Hosp 41(3):346\u2013356. https:\/\/doi.org\/10.7399\/fh.2017.41.3.10655","journal-title":"Farm Hosp"},{"key":"2785_CR112","unstructured":"Martinez JM; L\u00e1zaro L\u00f3pez A. Capacidad. In: Calleja Hern\u00e1ndez, Morillo Verdugo, ed. El modelo CMO en consultas externas de Farmacia Hospitalaria. Euromedice Vivactis 2016; pp 11\u201344"},{"key":"2785_CR113","unstructured":"Organizaci\u00f3n Mundial de la Salud. Informe mundial sobre el envejecimiento y la salud. Available at: http:\/\/www.who.int\/ageing\/publications\/world-report-2015\/es\/"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02785-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-019-02785-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02785-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,20]],"date-time":"2020-12-20T00:13:16Z","timestamp":1608423196000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-019-02785-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,21]]},"references-count":113,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["2785"],"URL":"https:\/\/doi.org\/10.1007\/s00228-019-02785-z","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,21]]},"assertion":[{"value":"9 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}